Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
Eli Lilly stock starts fresh week on front foot after rival Alzheimer trial fails
10:03am, Monday, 14'th Nov 2022
Eli Lilly and Co (NYSE:LLY) stock was moving higher as Roche revealed that an experimental rival treatment for Alzheimer's failed in a Phase III clinical trial. Roche earlier today announced that its
Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others
09:17am, Monday, 14'th Nov 2022
Roche said its experimental Alzheimer's treatment failed in two final-phase studies, leading Biogen stock to surge while others crumbled. The post Roche's Alzheimer's Drug Fails In Phase 3; Here's The
Twitter Shaves $15 Billon Off Eli Lilly's Market Cap
09:30am, Saturday, 12'th Nov 2022
Somehow, someone made it through Twitter's system to block accounts people use to impersonate other people and companies.
Eli Lilly stock dips after imposter account posts prank on Twitter
04:45pm, Friday, 11'th Nov 2022
Shares of Eli Lilly ticked downward after a fake account posed as the company on Twitter.
Why Are Healthcare Stocks Down Today?
04:31pm, Friday, 11'th Nov 2022
A scandal at Twitter is pushing healthcare stocks down today. Since Elon Musk took over the platform, much controversy has risen regarding its verification system.
Patience At The Right Time Made LLY Stock A Swing Trading Winner
04:30pm, Friday, 11'th Nov 2022
Patience is a virtue but knowing the right time to apply it helps make you money. The post Patience At The Right Time Made LLY Stock A Swing Trading Winner appeared first on Investor's Business Daily.
Eli Lilly shares fall after fake verified account tweets 'insulin is free now'
03:01pm, Friday, 11'th Nov 2022
Elon Musk's new pay-$8-for-Twitter-verification system has gone awry in a matter of days. Now, instead of just costing Twitter money, other companies are taking losses too.
Kari Lake, Lockheed Martin And Eli Lilly—Here Are The Companies, Celebrities And Politicians Impersonated In Twitter Blue Chaos
01:15pm, Friday, 11'th Nov 2022
Musk suspended his new verification program Twitter Blue on Friday and announced new rules for parody accounts.
Eli Lilly Clarifies It's Not Offering Free Insulin After Tweet From Fake Verified Account—As Chaos Unfolds On Twitter
05:34pm, Thursday, 10'th Nov 2022
New Twitter owner Elon Musk has come under fire for launching Twitter Blue, a program that allows any account to be verified for a monthly subscription, leading to widespread misinformation on the pla
CMI Stock Revisited: What Made It Work This Time?
05:06pm, Friday, 04'th Nov 2022
Two trades in the same stock just weeks apart. What was the secret of success the second time around?
Trading Ideas On The Upcoming CTAD 2022 Conference
03:27pm, Wednesday, 02'nd Nov 2022
The Clinical Trials on Alzheimer's Conference will take place from November 29, 2022 to December 2, 2022. Representatives of several listed companies will present data, including Eisai, Anavex, BioVie
Novo Nordisk Is Throwing Down The Gauntlet In Weight Loss As Eli Lilly Ramps Up
09:04am, Wednesday, 02'nd Nov 2022
Novo Nordisk is planning to boost production for weight-loss shot Wegovy as Eli Lilly angles for approval. NVO stock surged Wednesday.
Eli Lilly and Co (LLY) Q3 2022 Earnings Call Transcript
04:08pm, Tuesday, 01'st Nov 2022
Eli Lilly and Co (NYSE:LLY ) Q3 2022 Earnings Conference Call November 1, 2022 9:00 AM ET Company Participants Joe Fletcher - SVP, IR David Ricks - Chairman, CEO & President Anat Ashkenazi - SVP & CFO
Lilly's new diabetes drug doubled sales expectations. It may also be used to treat obesity
02:58pm, Tuesday, 01'st Nov 2022
Eli Lilly & Co. Inc.'s LLY, -3.40% steady transformation into a developer of both cutting-edge diabetes and obesity treatments is well underway.
Lilly (LLY) Beats on Q3 Earnings & Sales, Lowers '22 View
02:19pm, Tuesday, 01'st Nov 2022
Eli Lilly's (LLY) earnings and sales surpass third-quarter estimates. The company lowers 2022 financial view for the third time this year.
